Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2025-12-26 @ 2:58 AM
NCT ID:
NCT03523702
Pre Assignment Details:
Of the 42 patients who were consented into the trial, 5 were excluded prior to randomization. 4 of these patients did not meet inclusion/exclusion criteria and 1 was excluded based on personal reasons.
Of these 37 patients, based on assay results, 25 patients were determined to have a PD-L1 tumor expression level of ≥ 50% and 12 patients were observed to have a PD-L1 tumor expression level of \< 50%. The 25 patients with a PD-L1 tumor expression level ≥ 50% were enrolled into the study.
Recruitment Details:
Patients were enrolled between August 2018 and November 2021.
Study:
NCT03523702
Study Brief:
Results Section:
NCT03523702